Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Cooper

Showing results (211-220 of 229) with videos related to

Pageof 23
Sort By:
BMJ Open|February 22, 2024
PRECISION-TBI: a study protocol for a vanguard prospective cohort study to enhance understanding and management of moderate to severe traumatic brain injury in AustraliaToby Jeffcote, Camila R Battistuzzo, Mark P Plummer, et al.
The Medical Journal of Australia|June 10, 2022
People in intensive care with COVID-19: demographic and clinical features during the first, second, and third pandemic waves in AustraliaHusna Begum, Ary S Neto, Patricia Alliegro, et al.
JAMA|May 6, 2015
Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosisAndrew J Muir, Fred Poordad, Jacob Lalezari, et al.
Journal of Neurotrauma|June 11, 2015
A Consensus-Based Interpretation of the Benchmark Evidence from South American Trials: Treatment of Intracranial Pressure TrialRandall M Chesnut, Thomas P Bleck, Giuseppe Citerio, et al.
European Journal of Haematology|May 30, 2021
Bimodal expression of potential drug target CLL-1 (CLEC12A) on CD34+ blasts of AML patientsLok Lam Ngai, Connie Y Ma, Orla Maguire, et al.
Critical Care Explorations|June 14, 2021
Dysnatremia and 6-Month Functional Outcomes in Critically Ill Patients With Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort StudyJeremy Cohen, Anthony Delaney, James Anstey, et al.
The Medical Journal of Australia|December 16, 2020
Outcomes for patients with COVID-19 admitted to Australian intensive care units during the first four months of the pandemicAidan Jc Burrell, Breanna Pellegrini, Farhad Salimi, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 4, 2023
Comparison of baseline characteristics, treatment and celinical outcomes of critically ill COVID-19 patients admitted in the first and second waves in AustraliaAidan J C Burrell, Ary Serpa Neto, Tessa Broadley, et al.
Blood Advances|January 19, 2018
Heterozygous <i>RTEL1</i> variants in bone marrow failure and myeloid neoplasmsJudith C W Marsh, Fernanda Gutierrez-Rodrigues, James Cooper, et al.
Neurophotonics|April 1, 2026
CoMind R1: a time-resolved interferometric optical neuromonitoring system for pulsatile cerebral blood flow measurement at late times-of-flightVeronika Parfentyeva, Anurag Behera, Stella Avtzi, et al.
Pageof 23

Showing results (211-220 of 229) with videos related to

Sort By:
Pageof 23
BMJ Open|February 22, 2024
PRECISION-TBI: a study protocol for a vanguard prospective cohort study to enhance understanding and management of moderate to severe traumatic brain injury in AustraliaToby Jeffcote, Camila R Battistuzzo, Mark P Plummer, et al.
The Medical Journal of Australia|June 10, 2022
People in intensive care with COVID-19: demographic and clinical features during the first, second, and third pandemic waves in AustraliaHusna Begum, Ary S Neto, Patricia Alliegro, et al.
JAMA|May 6, 2015
Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosisAndrew J Muir, Fred Poordad, Jacob Lalezari, et al.
Journal of Neurotrauma|June 11, 2015
A Consensus-Based Interpretation of the Benchmark Evidence from South American Trials: Treatment of Intracranial Pressure TrialRandall M Chesnut, Thomas P Bleck, Giuseppe Citerio, et al.
European Journal of Haematology|May 30, 2021
Bimodal expression of potential drug target CLL-1 (CLEC12A) on CD34+ blasts of AML patientsLok Lam Ngai, Connie Y Ma, Orla Maguire, et al.
Critical Care Explorations|June 14, 2021
Dysnatremia and 6-Month Functional Outcomes in Critically Ill Patients With Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort StudyJeremy Cohen, Anthony Delaney, James Anstey, et al.
The Medical Journal of Australia|December 16, 2020
Outcomes for patients with COVID-19 admitted to Australian intensive care units during the first four months of the pandemicAidan Jc Burrell, Breanna Pellegrini, Farhad Salimi, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 4, 2023
Comparison of baseline characteristics, treatment and celinical outcomes of critically ill COVID-19 patients admitted in the first and second waves in AustraliaAidan J C Burrell, Ary Serpa Neto, Tessa Broadley, et al.
Blood Advances|January 19, 2018
Heterozygous <i>RTEL1</i> variants in bone marrow failure and myeloid neoplasmsJudith C W Marsh, Fernanda Gutierrez-Rodrigues, James Cooper, et al.
Neurophotonics|April 1, 2026
CoMind R1: a time-resolved interferometric optical neuromonitoring system for pulsatile cerebral blood flow measurement at late times-of-flightVeronika Parfentyeva, Anurag Behera, Stella Avtzi, et al.
Pageof 23